Cancer News and Research

Latest Cancer News and Research

Chemotherapy and tamoxifen reduce risk of second breast cancer

Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute.

28 Dec 2007

Breast cancer gene mutation more common in Hispanic, young black women

A genetic mutation already known to be more common in Ashkenazi Jewish breast cancer patients is also prevalent in Hispanic and young African-American women with breast cancer, according to one of the largest, multiracial studies of the mutation to date.

28 Dec 2007

Bevacizumab found to improve survival for patients with advanced breast cancer

Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.

28 Dec 2007

Scientists identifiy elusive telomere RNA subunit in single cell model

The Stowers Institute's Baumann Lab has identified the long-sought telomerase RNA gene in a single-cell research model.

28 Dec 2007

Anthracyclines improve survival in HER2-positive breast cancer patients

Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online December 25 in the Journal of the National Cancer Institute.

28 Dec 2007

Cancer stem cells may be at the root of brain tumors

Stem cells -- popularly known as a source of biological rejuvenation -- may play harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists have located cancer stem cells.

27 Dec 2007

Paradigm shift in TB: virulence factors, not antibiotics

Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.

27 Dec 2007

Australian researchers tackle antibiotic resistance

The development of antibiotic resistant strains of bacteria that are problematic and expensive to treat is a major healthcare problem around the world. The "selective pressure" of antibiotic usage inevitably results in the emergence and proliferation of resistant bacteria.

20 Dec 2007

Researchers prevent muscle weakness caused by myasthenia gravis

Severe muscle weakness caused by myasthenia gravis - a highly debilitating autoimmune disorder - can be prevented or reversed by blocking a key step in the immune response that brings on the disease, researchers at the Saint Louis University School of Medicine have found.

20 Dec 2007

Stop whole body scans says committee on radiation risk

An advisory committee to the British government has called for private health clinics to immediately stop offering whole body scans to the "worried well", because they carry too great a radiation risk.

20 Dec 2007

Microchip blood test detects cancers earlier

A new blood test which uses microchip technology may offer doctors the opportunity to detect cancers earlier and also monitor cancer treatment.

20 Dec 2007

Yale launches study of young women with heart attacks

The largest, most comprehensive study of young women with heart attacks - VIRGO (Variation in Recovery: Role of Gender on Outcomes in Young AMI patients) - was recently launched at Yale School of Medicine with a $9.7 million National Institutes of Health grant.

20 Dec 2007

Advanced melanoma - new treatment

University of Illinois at Chicago researchers are participating in a multi-center research trial to evaluate the safety and effectiveness of Allovectin-7, an investigational treatment for advanced melanoma.

20 Dec 2007

Study finds outcomes of high-risk cancer operations in 80-year-olds worse than reported

New research published in the December issue of The Journal of the American College of Surgeons shows that outcomes of high-risk cancer operations in 80-year-olds are considerably worse than reported in case studies and published survival statistics, which may lead to unrealistic expectations about the safety of these operations in the elderly.

20 Dec 2007